Trump signs executive order on Medicare

In a move toward making the public healthcare program more private, President Trump signed an executive order to strengthen Medicare Advantage.

MA plans are distributed through private healthcare companies contracted with CMS to provide Medicare benefits. MA plans can offer additional benefits, such as those addressing social determinants of health or focused on preventive care. MA plans currently cover about one-third of all Medicare beneficiaries, but most older U.S. adults overwhelmingly receive benefits under traditional Medicare.

In signing the executive order, Trump also took the opportunity to bash Medicare for all plans, arguing such a plan as introduced in the Senate would “destroy our current Medicare program.” According to Trump, such a system would result in delays for care. Trump made the announcement at The Villages, a large retirement community based in Florida, on Oct. 3.

Trump’s executive order pushes MA plans, which he said deliver efficient and value-based care. Trump’s order asks HHS to deliver more plans choices to senior within one year, with the HHS Secretary, currently Alex Azar, proposing a regulation and implementing other actions to enable access to more plans.

Specifically, the order asks HHS to change regulations and guidance to reduce barriers to Medicare Medical Savings Accounts and include a payment model allowing Medicare beneficiaries to share in savings from MA supplemental benefits. Lastly, Trump wants HHS to promote MA plans, by making sure traditional fee-for-service Medicare is not advantaged or promoted over MA.

Trump’s order further asks for other efficiencies within one year to facilitate MA plan growth and cut other regulations.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.